Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., St Louis, Missouri 63017, USA.
AAPS PharmSciTech. 2012 Mar;13(1):284-94. doi: 10.1208/s12249-011-9747-2. Epub 2012 Jan 13.
Trace amounts of metals are inevitably present in biotherapeutic products. They can arise from various sources. The impact of common formulation factors such as protein concentration, antioxidant, metal chelator concentration and type, surfactant, pH, and contact time with stainless steel on metal leachables was investigated by a design of experiments approach. Three major metal leachables, iron, chromium, and nickel were monitored by inductively coupled plasma-mass spectrometry. It was observed that among all the tested factors, contact time, metal chelator concentration, and protein concentration were statistically significant factors with higher temperature resulting in higher levels of leached metals. Within a pH range of 5.5-6.5, solution pH played a minor role for chromium leaching at 25°C. No statistically significant difference was observed due to type of chelator, presence of antioxidant, or surfactant. In order to optimize a biotherapeutic formulation to achieve a target drug product shelf life with acceptable quality, each formulation component must be evaluated for its impact.
痕量金属不可避免地存在于生物治疗产品中。它们可能来自各种来源。通过实验设计方法研究了常见制剂因素(如蛋白质浓度、抗氧化剂、金属螯合剂浓度和类型、表面活性剂、pH 值和与不锈钢接触时间)对可浸出金属的影响。采用电感耦合等离子体质谱法监测了三种主要的可浸出金属:铁、铬和镍。结果表明,在所测试的因素中,接触时间、金属螯合剂浓度和蛋白质浓度是具有统计学意义的重要因素,较高的温度导致更高水平的浸出金属。在 25°C 时,在 5.5-6.5 的 pH 范围内,溶液 pH 值对铬的浸出作用影响较小。由于螯合剂的类型、抗氧化剂的存在或表面活性剂的存在,没有观察到统计学上的显著差异。为了优化生物治疗制剂,以达到可接受质量的目标药物产品保质期,必须评估每个制剂成分对其的影响。